Article Details
Retrieved on: 2024-02-07 18:50:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Veklury (remdesivir), Gilead's intravenous antiviral coronavirus treatment, only brought in $720 million during the fourth quarter, representing a ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here